EUVIMEDEUVIMED entdecken
Crossref

Measuring Reversible Plasma Protein Binding for Covalent Inhibitors: Addressing Matrix Instability via Ultrafiltration coupled with LC-MS-RAM

Zachary Enlo-Scott, Matthias Wittwer, Janneke Keemink

Drug Metabolism and Disposition · 2026-11 · 100443

DOI: 10.1016/j.dmd.2026.100443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-11. Verfasst von Zachary Enlo-Scott und 2 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Gefördert von: F. Hoffmann-La Roche Ltd.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • F. Hoffmann-La Roche Ltd

Zitieren

APA

Enlo-Scott, Z., Wittwer, M., & Keemink, J. (2026). Measuring Reversible Plasma Protein Binding for Covalent Inhibitors: Addressing Matrix Instability via Ultrafiltration coupled with LC-MS-RAM. Drug Metabolism and Disposition, 100443. https://doi.org/10.1016/j.dmd.2026.100443

Vancouver

Enlo-Scott Z, Wittwer M, Keemink J. Measuring Reversible Plasma Protein Binding for Covalent Inhibitors: Addressing Matrix Instability via Ultrafiltration coupled with LC-MS-RAM. Drug Metabolism and Disposition. 2026:100443. doi:10.1016/j.dmd.2026.100443

BibTeX
@article{EnloScott2026,
  author = {Enlo-Scott, Zachary and Wittwer, Matthias and Keemink, Janneke},
  title = {Measuring Reversible Plasma Protein Binding for Covalent Inhibitors: Addressing Matrix Instability via Ultrafiltration coupled with LC-MS-RAM},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  pages = {100443},
  doi = {10.1016/j.dmd.2026.100443}
}
Kostenlos starten →